ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,889.79
-0.46%
US Tech 100
20,087.60
-0.19%
Dow Jones
43,455.64
0.11%
Brent Oil
73.535
0.95%
Bitcoin
96,280.14
2.03%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. SciSparc Ltd (SPRC) Quote

SciSparc Ltd

SciSparc Ltd (SPRC)

NASDAQ
0.2391
0.001
( 0.42% )
Updated: 10:06:50
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.2391
Bid
0.235
Ask
0.2391
Volume
36,658
0.234 Day's Range 0.2449
0.2055 52 Week Range 14.2199
Market Cap
646.448k
Previous Close
0.2381
Open
0.2381
Last Trade
100
@
0.2391
Last Trade Time
10:06:44
Financial Volume
$ 8,668
VWAP
0.236452
Average Volume (3m)
972,587
Shares Outstanding
2,703,674
Dividend Yield
-
PE Ratio
-0.13
Earnings Per Share (EPS)
-1.89
Revenue
2.88M
Net Profit
-5.12M

About SciSparc Ltd

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The compa... SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
scisparc.com
Headquarters
Tel Aviv, Center, Isr
Founded
-
SciSparc Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SPRC. The last closing price for SciSparc was $0.24. Over the last year, SciSparc shares have traded in a share price range of $ 0.2055 to $ 14.2199.

SciSparc currently has 2,703,674 shares outstanding. The market capitalization of SciSparc is $643,744.78 . SciSparc has a price to earnings ratio (PE ratio) of -0.13.

Ask ADVFN Intelligence (AI)

SPRC Latest News

More News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

November 04 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

October 23 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

October 22 2024
Edgar (US Regulatory)

SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment

FDA confirms that SciSparc’s study may proceed only a month after application submission TEL AVIV, Israel, Sept. 30, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or...

September 30 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

September 27 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

September 26 2024
Edgar (US Regulatory)

SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX

The intended selling valuation represents an increase of 47% from the valuation at the time of SciSparc’s initial investment in MitoCareX Bio TEL AVIV, Israel, Sept. 26, 2024 (GLOBE NEWSWIRE...

September 26 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

September 23 2024
Edgar (US Regulatory)

SciSparc Receives FDA Approval to Initiate Phase IIb Clinical Trial for Tourette Syndrome Treatment

FDA confirms that SciSparc’s study may proceed following the application submission a month ago TEL AVIV, Israel, Sept. 23, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or...

September 23 2024
GlobeNewswire Inc.

SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome Treatment

Yale Child Study Center at the Yale School of Medicine in the USA, Hannover Medical School in Germany and Tel Aviv Sourasky Medical Center in Israel will take part in the trial TEL AVIV, Israel...

September 18 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00020.08371703641690.23890.24490.21252682810.23161342CS
40.00311.313559322030.2360.25540.21063730520.23506349CS
12-0.1109-31.68571428570.350.38460.20559725870.2708939CS
26-0.9709-80.23966942151.211.310.205520624200.46024239CS
52-5.7109-95.9815126055.9514.21990.205515649332.16022525CS
156-181.7609-99.8686263736182184.080.2055157426414.98767615CS
260-181.7609-99.8686263736182184.080.2055157426414.98767615CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WORXSCWorx Corporation
$ 2.235
(128.06%)
86.61M
SKKSKK Holdings Limited
$ 9.42
(106.58%)
3.18M
CRNCCerence Inc
$ 5.0582
(79.37%)
12.46M
SPAISafe Pro Group Inc
$ 4.41
(37.81%)
35.54M
CDTConduit Pharmaceuticals Inc
$ 0.1236
(33.91%)
425.15M
PYXSPyxis Oncology Inc
$ 2.0684
(-45.85%)
7.03M
KURAKura Oncology Inc
$ 10.0068
(-37.10%)
5.74M
SHOTWSafety Shot Inc
$ 0.1001
(-33.27%)
2.5k
AGFYAgrify Corporation
$ 25.95
(-33.05%)
295.62k
BLRXBioLineRx Ltd
$ 0.3717
(-31.82%)
4.77M
CDTConduit Pharmaceuticals Inc
$ 0.1228
(33.04%)
425.18M
AKTSAkoustis Technologies Inc
$ 0.0979
(12.40%)
165.19M
NVDANVIDIA Corporation
$ 144.86
(-0.71%)
140.13M
WORXSCWorx Corporation
$ 2.24
(128.57%)
86.64M
ELABElevai Labs Inc
$ 0.02035
(-4.91%)
77.43M

SPRC Discussion

View Posts
Awl416 Awl416 2 months ago
Fall for it if ya want

SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX
👍️0
Monksdream Monksdream 2 months ago
SPRC new 52;week low
👍️0
Monksdream Monksdream 2 months ago
SPRC new 52 week low
👍️0
Monksdream Monksdream 2 months ago
SPRC new 52 week low

👍️0
Awl416 Awl416 3 months ago
Talk about jumping off a cliff…
👍️0
glenn1919 glenn1919 3 months ago
SPRC.............................https://stockcharts.com/h-sc/ui?s=SPRC&p=W&b=5&g=0&id=p86431144783
👍️0
Pastor Phil Pastor Phil 3 months ago
I’m sold out
👍️0
webprods webprods 3 months ago
Great news today. 1.63 coming
👍️0
webprods webprods 3 months ago
32.63% pm . Actual
👍️0
Pastor Phil Pastor Phil 3 months ago
Up over 30% premarket
👍️0
webprods webprods 3 months ago
OS is only 7.36 million. 7,360,000
👍️0
webprods webprods 3 months ago
Here you are. As of August 15, 2024, SciSparc Ltd. (SPRC) stock had 7.36 million shares outstanding. The company's public float was 2.45 million. Good luck. Closer to merger higher share price. I think that double dollars is possible
👍️0
Pastor Phil Pastor Phil 3 months ago
Some spike on the newz here. Is it dun?
👍️0
Awl416 Awl416 3 months ago
Oh stop it
👍️0
Awl416 Awl416 3 months ago
Wasn’t rocket science
👍️0
hondaboost hondaboost 3 months ago
Anyone could tell SPRC O/S, please? Thanks.
👍️0
Awl416 Awl416 3 months ago
Yawn….
👍️0
glenn1919 glenn1919 3 months ago
SPRC..........................https://stockcharts.com/h-sc/ui?s=SPRC&p=W&b=5&g=0&id=p86431144783
👍️0
BeamMeUpScotty BeamMeUpScotty 3 months ago
They’re putting the deal to a shareholder vote. Sounds like they have agreed terms and just have to give the required amount of time for shareholders to vote for the deal.
👍️0
Awl416 Awl416 3 months ago
Don’t fall for it…
👍️0
Monksdream Monksdream 3 months ago
SPRC new 52 week low
👍️0
Monksdream Monksdream 4 months ago
SPRC new 52 week low
👍️0
glenn1919 glenn1919 4 months ago
SPRC........................https://stockcharts.com/h-sc/ui?s=SPRC&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 5 months ago
SPRC new 52 week low
👍️0
Monksdream Monksdream 5 months ago
SPRC new 52 week low
👍️0
Monksdream Monksdream 5 months ago
SPRC new 52 week low
👍️0
Monksdream Monksdream 6 months ago
SPRC 10Q expected 5/30
👍️0
Monksdream Monksdream 7 months ago
SPRC new 52 lo

👍️0
Monksdream Monksdream 7 months ago
SPRC new 52 lo
👍️0
DK11 DK11 7 months ago
Totally scam got me a little. Out
👍️0
Monksdream Monksdream 7 months ago
SPRC new 52 lo totally ridiculous
👍️0
DK11 DK11 7 months ago
Go for it !!!
I just get pissed when Benzinga has Great News comes out for CVKD, BSFC, and SPRC and they all immediately go down
and I mean far down. So, you can't even trust good news now, to me it's time to take a rest. That's stepping over the line.
👍️0
Monksdream Monksdream 7 months ago
But what about the gold and silver mining stocks which have been in rally mode since February
👍️0
DK11 DK11 7 months ago
Less of two evils, I will take Trump Like Hungarian President said there was no war but peace with Trump inflation under control, and
The Stock Market for Traders was much better.
Yes, Trump was better.
👍️0
peterus peterus 7 months ago
you think TRUMP is ?
👍️0
DK11 DK11 7 months ago
Hey everyone, this stock is so good. Every time I go on my screener where I check over 1,000 stocks, usually I see a sea of red. This is a great time to get out of stock trading til we get a competent President. I am done for now
👍️0
Awl416 Awl416 7 months ago
Fluff….
👍️0
Monksdream Monksdream 7 months ago
Here we go again
Another boing off a 52 low due to another fluff news release
👍️0
Monksdream Monksdream 7 months ago
SPRC new 52 lo
👍️0
Monksdream Monksdream 8 months ago
SPRC under $2
👍️0
HoldEm777 HoldEm777 8 months ago
Got to be getting close to turning…
👍️0
Awl416 Awl416 8 months ago
SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research

Fluffy - Keep trying
👍️0
Awl416 Awl416 8 months ago
Below 1.85 lights out
👍️0
Awl416 Awl416 8 months ago
Red!
👍️0
Awl416 Awl416 8 months ago
Yawn….
👍️0
Monksdream Monksdream 8 months ago
SPRC No 3 on the Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 8 months ago
SPRC new 52 lo
👍️0
Monksdream Monksdream 8 months ago
SPRC new 52 week low
👍️0
TheFinalCD TheFinalCD 8 months ago
https://classic.clinicaltrials.gov/ct2/show/NCT05182697
👍️0
TheFinalCD TheFinalCD 8 months ago
$SPRC *AUTISM* NEWS https://www.globenewswire.com/news-release/2024/03/08/2843039/0/en/SciSparc-Announces-Enrollment-of-First-Patient-for-its-Clinical-Trial-for-Children-with-Autism-Spectrum-Disorder.html
👍️0

Your Recent History

NASDAQ
SPRC
SciSparc
USOTC
SISPF
Science In Sport (PK)
USOTC
SECI
Sector 10 (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved